Skip to main content

Fabrizio Esquivel Segovia

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Fabrizio Esquivel Segovia

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Bárbara Bolonci

Bárbara Bolonci

Research technician
Epidemiology and Public Health
Read more
Jorge Fernandez Engroba

Jorge Fernandez Engroba

Predoctoral researcher
Ophtalmology
Read more
Anna Lazaro Bracons

Anna Lazaro Bracons

Gestió i Administració
Business Development Unit
Directorate of Innovation and Business Development
Read more
Jorge Rubio Ruiz

Jorge Rubio Ruiz

Senior researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.